CD38 is a cell surface antigen that is expressed or overexpressed in several different hematologic malignancies including multiple myeloma (MM), T-cell acute lymphoblastic leukemia (T-ALL), and others including some BPDCNs. This evidence concerns the gene CD38 and Miyoshi myopathy.